Combination with Optimized Background Therapy for the Treatment of Experienced CCR5-Tropic HIV-1 Infected Children 2-18 Years Clinical Trial A Phase 1B Study of the Safety Patricia Emmanuel (PI) Pediatrics pharmacokenetics, HIV therapy and Pharmacokinetics of Ritonavir-Boosted Elvitegravir (EVG/r) Plus a Background Regimen (BR) in HIV-1 Infected, Antiretroviral Experienced Adolescents Clinical Trial International Maternal Pediatric Patricia Emmanuel (PI) Pediatrics Prevention of maternal to child transmission, Adolescent AIDS Clinical Trials pediatric treatment studies Group Clinical Trial Adolescent Medicine Trials Patricia Emmanuel (PI) Pediatrics Multicenter trials group, prevention and Network II treatment studies in HIV at risk and infected youth Clinical Trial Efficacy and Safety of Vicriviroc Chararut Somboonwit (PI) primary therapy in HIV-Infected Treatment-Naïve Subjects Clinical Trial A Phase II randomized, Todd Wills (PI) Internal Medicine HIV therapy placebo-controlled trial to investigate the efficacy, tolerability and safety of TMC125 as part of an ART including TMC114/RTV and an investigator-selected OBR in HIV-1 infected subjects Clinical Trial A Phase 3, Randomized, Todd Wills (PI) Internal Medicine HIV therapy Study to Evaluate the Safety and Efficacy of Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered with Emtricitabine/Tenofovir
Combination with Optimized Background Therapy for the Treatment of CCR5-Tropic HIV-1 Infected Children 2-18 Years Clinical Trial A Phase 1B Study of the Safety and Pharmacokinetics of Ritonavir-Boosted Elvitegravir (EVG/r) Plus a Background Regimen (BR) in HIV-1 Infected, Antiretroviral Adolescents Patricia Emmanuel (PI) Pediatrics pharmacokenetics, HIV therapy Clinical Trial International Maternal Pediatric Adolescent AIDS Clinical Trials Group Patricia Emmanuel (PI) Pediatrics Prevention of maternal to child transmission, pediatric treatment studies Clinical Trial Adolescent Medicine Trials Network II Patricia Emmanuel (PI) Pediatrics Multicenter trials group, prevention and treatment studies in HIV at risk and infected youth Clinical Trial Efficacy and Safety of Vicriviroc in HIV-Infected Treatment-Naïve Subjects Chararut Somboonwit (PI) primary therapy Clinical Trial A Phase II randomized, placebo-controlled trial to investigate the efficacy, tolerability and safety of TMC125 as part of an ART including TMC114/RTV and an investigator-selected OBR in HIV-1 infected subjects Todd Wills (PI) Internal Medicine HIV therapy Clinical Trial A Phase 3, Randomized, Study to Evaluate the Safety and Efficacy of Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered with Emtricitabine/Tenofovir Todd Wills (PI) Internal Medicine HIV therapy Experienced Experienced